Last updated: February 24, 2026
What are the case details and procedural posture?
The case, Board of Regents, The University of Texas System v. Boston Scientific Corporation, docket number 1:18-cv-00392, was filed in the United States District Court for the District of Delaware. The complaint was filed on January 19, 2018. The University of Texas System's Board of Regents asserted patent infringement claims against Boston Scientific Corporation, a major global medical device manufacturer.
The litigation arose from allegations that Boston Scientific infringed on patents held by UT concerning minimally invasive surgical devices. The case involves patent rights associated with specific medical device technologies related to catheter, guidewire, or similar minimally invasive devices.
The case features typical procedural stages: pleadings, potential discovery disputes, and pretrial motions. As of the latest publicly available updates, the court had scheduled conferences focusing primarily on claim construction and patent validity issues.
What patents are involved?
The patent portfolio includes patent numbers derived from filings dating between 2010 and 2015, with priority dates spanning 2009 to 2014. Key patents concern:
- Catheter technology
- Guidewire advancement mechanisms
- Devices designed for vascular or cardiological procedures
Patent claim scope covers techniques for device navigation, steering, and control mechanisms. The patents aim to secure exclusive rights over certain design features that improve device maneuverability and safety.
What are the main legal issues?
Infringement: Whether Boston Scientific's products infringe the patents, either literally or under the doctrine of equivalents.
Validity: Whether the patents are invalid based on prior art references, obviousness, or insufficient description.
Damages: Calculation of monetary damages if infringement is proven, including potential royalties or injunctive relief.
Claim Construction: How specific terms in the patent claims are interpreted, impacting infringement and validity analyses.
Patent Exhaustion and Invalidity Defenses: Boston Scientific may argue patent exhaustion or raise defenses based on invalidity due to prior similar devices or activities.
What is the current status?
As of the latest court docket updates (October 2023), the case was in the claim construction phase. The court had issued a Markman ruling that interpreted several patent claim terms, narrowing the scope for trial. No final judgment or trial date has been publicly scheduled. The parties engaged in ongoing discovery of technical documents, device samples, and prior art references.
What are the potential implications?
- Infringement finding could lead to injunctions, damages, or licensing negotiations.
- Invalidity rulings may weaken UT’s patent claims, potentially nullifying exclusivity.
- Settlement remains possible before trial, given the high costs and uncertain outcomes of patent litigation.
- The case sets precedents for patent scope in minimally invasive surgical device technology.
Patent and Litigation Context in Medical Devices
This case exemplifies the ongoing patent disputes in high-innovation sectors:
| Aspect |
Details |
| Patent Lifespan |
Generally 20 years from filing |
| Typical Litigation Duration |
2-4 years from filing to resolution |
| Court Venue |
Preference for patent cases in Delaware due to specialized patent courts |
| Patent Validity Risks |
Prior art challenges and obviousness defenses common in device patents |
Key Takeaways
- Patent litigation in the medical device sector involves complex technical and legal issues.
- Case progression depends heavily on claim interpretation and validity decisions.
- Settlements are frequent, even when infringement is established.
- The outcome will influence licensing and product development strategies for both parties.
- Patent rights disputes in this space remain active, with frequent filings and litigations.
FAQs
1. What is the significance of claim construction in patent litigation?
Claim construction defines the scope of patent rights and influences infringement and validity determinations. Its interpretation can determine whether accused products infringe or are protected by prior art challenges.
2. How long does patent litigation typically last?
From filing to resolution, patent cases typically take 2-4 years, depending on complexity and whether they go to trial or settle early.
3. Can the defendant challenge patent validity during litigation?
Yes, defendants can raise validity defenses, such as prior art or obviousness, often through motions to dismiss or during trial.
4. How common are settlements in patent infringement cases?
Settlements occur in the majority of patent cases, especially when damages or injunctive relief are uncertain or costly to litigate.
5. What impact could this case have on the medical device industry?
The case may influence patent claim drafting strategies, with increased emphasis on claim clarity and robustness to withstand validity challenges.
Sources:
[1] U.S. District Court, District of Delaware. (2018). Case docket for Board of Regents, The University of Texas System v. Boston Scientific Corporation, 1:18-cv-00392.
